A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir.

Pao-Yuan HuangSherry Yueh-Hsia ChiuKuo-Chin ChangPo-Lin TsengYi-Hao YenMing-Chao TsaiJing-Houng WangKwong-Ming KeeChien-Hung ChenChao-Hung HungKing-Wah ChiuTsung-Hui Hu

Published in: Hepatology international (2021)

This study suggested CHB patients treated with TDF may experience increased risks of bone loss and renal deficits compared to those treated with ETV.

Keyphrases

bone mineral density
bone loss
postmenopausal women
body composition
traumatic brain injury
hepatitis b virus
acute lymphoblastic leukemia
climate change
risk assessment